1. Home
  2. COEP vs IZEA Comparison

COEP vs IZEA Comparison

Compare COEP & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • IZEA
  • Stock Information
  • Founded
  • COEP 2017
  • IZEA 2006
  • Country
  • COEP United States
  • IZEA United States
  • Employees
  • COEP N/A
  • IZEA N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • IZEA Advertising
  • Sector
  • COEP Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • COEP 27.4M
  • IZEA 44.6M
  • IPO Year
  • COEP N/A
  • IZEA N/A
  • Fundamental
  • Price
  • COEP $10.96
  • IZEA $3.39
  • Analyst Decision
  • COEP
  • IZEA
  • Analyst Count
  • COEP 0
  • IZEA 0
  • Target Price
  • COEP N/A
  • IZEA N/A
  • AVG Volume (30 Days)
  • COEP 39.2K
  • IZEA 52.8K
  • Earning Date
  • COEP 08-15-2025
  • IZEA 08-13-2025
  • Dividend Yield
  • COEP N/A
  • IZEA N/A
  • EPS Growth
  • COEP N/A
  • IZEA N/A
  • EPS
  • COEP N/A
  • IZEA N/A
  • Revenue
  • COEP $62,874.00
  • IZEA $36,896,490.00
  • Revenue This Year
  • COEP N/A
  • IZEA $22.24
  • Revenue Next Year
  • COEP N/A
  • IZEA N/A
  • P/E Ratio
  • COEP N/A
  • IZEA N/A
  • Revenue Growth
  • COEP N/A
  • IZEA 7.17
  • 52 Week Low
  • COEP $2.31
  • IZEA $1.68
  • 52 Week High
  • COEP $13.70
  • IZEA $3.49
  • Technical
  • Relative Strength Index (RSI)
  • COEP 64.36
  • IZEA 74.88
  • Support Level
  • COEP $7.25
  • IZEA $2.55
  • Resistance Level
  • COEP $10.00
  • IZEA $3.15
  • Average True Range (ATR)
  • COEP 0.52
  • IZEA 0.17
  • MACD
  • COEP 0.27
  • IZEA 0.08
  • Stochastic Oscillator
  • COEP 93.91
  • IZEA 82.65

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: